drugset / Trial / NCT02242305
Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort
RandomizedParallel-groupDouble-blindTreatment
Summary
In contrast with Hyoscine Butylbromide Capsule 10mg, Study is to evaluate the efficacy and safety of Hyoscine Butylbromide tablets 10 mg (20mg, 3 times daily, orally) over a period of 3 days for the treatment of occasional or recurrent episodes of self-reported gastric or intestinal spasm-like pain or discomfort
Timeline
- Start
- 2008-11-01
- Primary completion
- 2009-07-20
- Completion
- 2009-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyoscine butylbromide | Unknown | 10 mg | Oral |
| Subject | Hyoscine butylbromide | Unknown | 20 mg | Oral |
Indications
No indication recorded.